Abstract
Scalene node biopsy is an additional adjunct to the establishment of a diagnosis in many lesions and an important aid in the determination and selection of patients with pulmonary lesions for thoracotomy. The incidence of positive nodes in proved cases of primary pulmonary carcinoma was 19 per cent in our series. In the instances of non-palpable scalene nodes, the incidence was 8.1 per cent. In a group of patients with pulmonary carcinoma who were considered clinically operable, the scalene node biopsy was positive in 10 per cent. This factor may be an important consideration in selection of patients for exploration and resectability. A properly performed scalene node biopsy should become a definite part of the over-all work-up and evaluation of patients with pulmonary lesions, particularly those with primary carcinoma.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
